Cargando…

A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities

PURPOSE: Although doxorubicin chemotherapeutic drug is commonly used to treat various solid and hematological tumors, its clinical use is restricted because of its adverse effects on the normal cells/tissues, especially cardiotoxicity. The use of resveratrol may mitigate the doxorubicin-induced card...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Li-Feng, Lan, Huan-Rong, Li, Xue-Min, Jin, Ke-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405305/
https://www.ncbi.nlm.nih.gov/pubmed/34471463
http://dx.doi.org/10.1155/2021/2951697
_version_ 1783746304537526272
author Hu, Li-Feng
Lan, Huan-Rong
Li, Xue-Min
Jin, Ke-Tao
author_facet Hu, Li-Feng
Lan, Huan-Rong
Li, Xue-Min
Jin, Ke-Tao
author_sort Hu, Li-Feng
collection PubMed
description PURPOSE: Although doxorubicin chemotherapeutic drug is commonly used to treat various solid and hematological tumors, its clinical use is restricted because of its adverse effects on the normal cells/tissues, especially cardiotoxicity. The use of resveratrol may mitigate the doxorubicin-induced cardiotoxic effects. For this aim, we systematically reviewed the potential chemoprotective effects of resveratrol against the doxorubicin-induced cardiotoxicity. METHODS: In the current study, a systematic search was performed based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline for the identification of all relevant studies on “the role of resveratrol on doxorubicin-induced cardiotoxicity” in the electronic databases of Web of Science, PubMed, and Scopus up to March 2021 using search terms in their titles and abstracts. Two hundred and eighteen articles were screened in accordance with a predefined set of inclusion and exclusion criteria. Finally, 33 eligible articles were included in this systematic review. RESULTS: The in vitro and in vivo findings demonstrated a decreased cell survival, increased mortality, decreased heart weight, and increased ascites in the doxorubicin-treated groups compared to the control groups. The combined treatment of resveratrol and doxorubicin showed an opposite pattern than the doxorubicin-treated groups alone. Furthermore, this chemotherapeutic agent induced the biochemical and histopathological changes on the cardiac cells/tissue; however, the results (for most of the cases) revealed that these alterations induced by doxorubicin were reversed near to normal levels (control groups) by resveratrol coadministration. CONCLUSION: The results of this systematic review stated that coadministration of resveratrol alleviates the doxorubicin-induced cardiotoxicity. Resveratrol exerts these chemoprotective effects through several main mechanisms of antioxidant, antiapoptosis, and anti-inflammatory.
format Online
Article
Text
id pubmed-8405305
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-84053052021-08-31 A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities Hu, Li-Feng Lan, Huan-Rong Li, Xue-Min Jin, Ke-Tao Oxid Med Cell Longev Review Article PURPOSE: Although doxorubicin chemotherapeutic drug is commonly used to treat various solid and hematological tumors, its clinical use is restricted because of its adverse effects on the normal cells/tissues, especially cardiotoxicity. The use of resveratrol may mitigate the doxorubicin-induced cardiotoxic effects. For this aim, we systematically reviewed the potential chemoprotective effects of resveratrol against the doxorubicin-induced cardiotoxicity. METHODS: In the current study, a systematic search was performed based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline for the identification of all relevant studies on “the role of resveratrol on doxorubicin-induced cardiotoxicity” in the electronic databases of Web of Science, PubMed, and Scopus up to March 2021 using search terms in their titles and abstracts. Two hundred and eighteen articles were screened in accordance with a predefined set of inclusion and exclusion criteria. Finally, 33 eligible articles were included in this systematic review. RESULTS: The in vitro and in vivo findings demonstrated a decreased cell survival, increased mortality, decreased heart weight, and increased ascites in the doxorubicin-treated groups compared to the control groups. The combined treatment of resveratrol and doxorubicin showed an opposite pattern than the doxorubicin-treated groups alone. Furthermore, this chemotherapeutic agent induced the biochemical and histopathological changes on the cardiac cells/tissue; however, the results (for most of the cases) revealed that these alterations induced by doxorubicin were reversed near to normal levels (control groups) by resveratrol coadministration. CONCLUSION: The results of this systematic review stated that coadministration of resveratrol alleviates the doxorubicin-induced cardiotoxicity. Resveratrol exerts these chemoprotective effects through several main mechanisms of antioxidant, antiapoptosis, and anti-inflammatory. Hindawi 2021-08-22 /pmc/articles/PMC8405305/ /pubmed/34471463 http://dx.doi.org/10.1155/2021/2951697 Text en Copyright © 2021 Li-Feng Hu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Hu, Li-Feng
Lan, Huan-Rong
Li, Xue-Min
Jin, Ke-Tao
A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities
title A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities
title_full A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities
title_fullStr A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities
title_full_unstemmed A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities
title_short A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities
title_sort systematic review of the potential chemoprotective effects of resveratrol on doxorubicin-induced cardiotoxicity: focus on the antioxidant, antiapoptotic, and anti-inflammatory activities
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405305/
https://www.ncbi.nlm.nih.gov/pubmed/34471463
http://dx.doi.org/10.1155/2021/2951697
work_keys_str_mv AT hulifeng asystematicreviewofthepotentialchemoprotectiveeffectsofresveratrolondoxorubicininducedcardiotoxicityfocusontheantioxidantantiapoptoticandantiinflammatoryactivities
AT lanhuanrong asystematicreviewofthepotentialchemoprotectiveeffectsofresveratrolondoxorubicininducedcardiotoxicityfocusontheantioxidantantiapoptoticandantiinflammatoryactivities
AT lixuemin asystematicreviewofthepotentialchemoprotectiveeffectsofresveratrolondoxorubicininducedcardiotoxicityfocusontheantioxidantantiapoptoticandantiinflammatoryactivities
AT jinketao asystematicreviewofthepotentialchemoprotectiveeffectsofresveratrolondoxorubicininducedcardiotoxicityfocusontheantioxidantantiapoptoticandantiinflammatoryactivities
AT hulifeng systematicreviewofthepotentialchemoprotectiveeffectsofresveratrolondoxorubicininducedcardiotoxicityfocusontheantioxidantantiapoptoticandantiinflammatoryactivities
AT lanhuanrong systematicreviewofthepotentialchemoprotectiveeffectsofresveratrolondoxorubicininducedcardiotoxicityfocusontheantioxidantantiapoptoticandantiinflammatoryactivities
AT lixuemin systematicreviewofthepotentialchemoprotectiveeffectsofresveratrolondoxorubicininducedcardiotoxicityfocusontheantioxidantantiapoptoticandantiinflammatoryactivities
AT jinketao systematicreviewofthepotentialchemoprotectiveeffectsofresveratrolondoxorubicininducedcardiotoxicityfocusontheantioxidantantiapoptoticandantiinflammatoryactivities